Nebulised ipratropium bromide is not indicated in bronchiolitis.

Date First Published:
March 1, 2000
Last Updated:
May 16, 2001
Report by:
Martin Smith, Specialist Registrar (Manchester Royal Infirmary)
Search checked by:
Mohammed Al Zarad, Manchester Royal Infirmary
Three-Part Question:
In [infants with acute bronchiolitis] does [treatment with nebulised ipratropium bromide] reduce [the clinical severity or the length of stay]?
Clinical Scenario:
A 6 month old baby with 3 day history of coryzal symptoms, increasing cough and wheeze presents to the emergency department. Your clinical diagnosis is bronchiolitis. You wonder whether the addition of nebulised ipratropium will improve the clinical condition.
Search Strategy:
Medline 1966-07/99 using the OVID interface.
Search Details:
({exp bronchiolitis OR exp bronchiolitis, viral OR exp respiratory syncitial virus infections OR exp respiratory syncitial virus, human OR RSV.mp OR bronchiolitis.mp} AND {atrovent.mp OR exp ipratropium OR ipratropium.mp}) LIMIT to human AND english.
Outcome:
13 papers found of which 8 were irrelevant or of insufficient quality. The remaining 5 papers are shown in the table.
Relevant Paper(s):
Study Title Patient Group Study type (level of evidence) Outcomes Key results Study Weaknesses
Ineffectiveness of ipratropium bromide in acute bronchiolitis. Henry RL, Milner AD, Stokes GM. 1983 UK. 66 infants (7-52 wks).
Ipratropium vs saline.
PRCT Clinical severity score No significant improvement Randomisation and blinding not explained.
No basic data or results presented.
Parental/nurse subjective assessment No significant difference
Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Wang EE, Milner R, Allen U, Maj H. 1992 Canada. 62 children (2 months to 2 years).
Salbutamol or placebo vs ipratropium or placebo.
PRCT Pulse oximetry No significant change Possible selection bias as all patients received emergency room treatment.
Infrequent observations.
Clinical severity score No significant change
Hospitalisation No significant difference
Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Schuh S, Johnson D, Canny G, et al. 1992 Canada. 69 children (6 weeks to 2 years).
Albuterol and saline vs albuterol and ipratropium.
PRCT Respiratory rate No significant difference
Accessory muscle score No significant difference
Wheeze score No significant difference
Oxygen saturation No significant difference
Hospitalization rate 17 vs 10
The role of bronchodilators in the management of bronchiolitis: a clinical trial. Chowdhury D, al Howasi M, Khalil M, al-Frayh AS, Chowdhury S, Ramia S. 1994 Saudi Arabia. 89 children (6 wks-24 mon).
Ipratropium alone vs salbutamol alone vs ipratropium and salbutamol vs saline.
PRCT Clinical severity score No significant difference in all groups Small groups with no blinding.
Not all patients included.
Admission days No significant difference in all groups
Efficacy of bronchodilators in the treatment of bronchiolitis. Goh A, Chay OM, Foo AL, Ong EK. 1997 Singapore. 89 children.
Neb salbutamol vs neb ipratropium vs neb saline vs humidified oxygen.
PRCT Clinical severity score No significant difference Small numbers with possible type 2 error.
Second control group added later.
Length of stay No significant difference
Author Commentary:
All the trials found have faults, however not one showed a benefit from nebulised ipratropium in this condition.
Bottom Line:
Nebulised ipratropium bromide is not indicated in bronchiolitis.
References:
  1. Henry RL, Milner AD, Stokes GM.. Ineffectiveness of ipratropium bromide in acute bronchiolitis.
  2. Wang EE, Milner R, Allen U, Maj H.. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial.
  3. Schuh S, Johnson D, Canny G, et al.. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis.
  4. Chowdhury D, al Howasi M, Khalil M, al-Frayh AS, Chowdhury S, Ramia S.. The role of bronchodilators in the management of bronchiolitis: a clinical trial.
  5. Goh A, Chay OM, Foo AL, Ong EK.. Efficacy of bronchodilators in the treatment of bronchiolitis.